Entera Bio Ltd. (ENTX)
Nasdaq: ENTX · Biological Products, (No Diagnostic Substances) · Jerusalem · filing with the SEC since 2015
Who owns Entera Bio Ltd.
As filed with the SECHolders of 5% or more
4
Bvf Partners L P/il holds 9.99% of Ordinary Shares, par value NIS 0.0000769 per share, as its SCHEDULE 13D filed Aug 4, 2026 says.
Directors and officers
12
report now, of 19 people on the record since 2022. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Bvf Partners L P/il
SCHEDULE 13D · filed Aug 4, 2026 · Ordinary Shares, par value NIS 0.0000769 per share
OPKO Health, Inc.
SCHEDULE 13G · filed Apr 2, 2025 · Ordinary Shares Nominal value of NIS 0.0000769 per share
TCG Crossover GP III, LLC
SCHEDULE 13G · filed Aug 4, 2026 · Ordinary Shares, par value of NIS $0.0000769
Vivo Opportunity, LLC
SCHEDULE 13G · filed Aug 4, 2026 · Ordinary Shares, par value of NIS 0.0000769
Longitude Capital Partners V, LLC
SCHEDULE 13G · filed Aug 4, 2026 · Ordinary Shares, par value per share NIS 0.0000769 · reported falling below 5%
Seven Fleet Capital Management LP
SCHEDULE 13G · filed Aug 4, 2026 · Ordinary Shares, par value NIS 0.0000769 per share · reported falling below 5%
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed Nov 14, 2025 · Ordinary shares, par value NIS 0.0000769 per share · reported falling below 5%, from 6.8% in Jan 6, 2025
What ENTX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Entera Bio Ltd
An entity · legal entity · owns, named in the 10-K filed Mar 27, 2026
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 27, 2026.
Insider tradesForm 4
0sales
8purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 20 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Ellis Sean | director | 0 | $0 | 0 | 2 | $0 |
| Germano Geno J | director | 0 | $0 | 0 | 2 | $100,000 |
| Rubin Steven D | director | 0 | $0 | 0 | 2 | $0 |
| Toledano Miranda Jayne | Chief Executive Officer | 0 | $0 | 0 | 1 | $0 |
| Taitel Haya | director | 0 | $0 | 0 | 1 | $0 |